←
Impens Lab56 posts
Impens Lab avatar

Impens Lab

@ImpensLab

We study host-bacteria interactions using Listeria and MS-based Proteomics with a focus on Ubiquitin-like modifications (e.g. ISG15) and MHC complex peptides.

◷ Joined October 2021▧ 1 Photos and videos
Patrick Willems avatar
⟳ Impens Lab retweeted
Patrick Willems@Patrick14342109·16 Mar 2025

🚀 Boosting bacterial immunopeptide discovery! Our bioinformatics workflow integrates 4 search engines with follow-up rescoring to enhance ID by 27%, maximizing the discovery of vaccine candidates. Applied to timsTOF/Thermo data🦠💉 @ImpensLab 🔗Read: pubs.acs.org/doi/full/10.102…

Patrick Willems avatar
⟳ Impens Lab retweeted
Patrick Willems@Patrick14342109·24 Nov 2024

Happy to share our immunopeptidomics pipeline using four search engine with follow-up rescoring to boost confident IDs. Also applied to timsTOF SCP data! @ImpensLab @compomics Preprint: biorxiv.org/content/10.1101/…

Impens Lab avatar
Impens Lab@ImpensLab·14 Aug 2024

Excited to share our latest MCP article uncovering > 6,000 MHC class I immunopeptides in Listeria-infected mice, including 12 Listeria peptides and a potent CD8+ T cell epitope. Many thanks to all co-authors for the excellent work! Read more at doi.org/10.1016/j.mcpro.2024…

An Staes avatar
⟳ Impens Lab retweeted
An Staes@AnStaes·26 Apr 2024

Here it is: our paper on the benefit of using in silico predicted libraries in DIA 🎉🎉🎉😎🙏 pubs.acs.org/doi/10.1021/acs… @KrisGevaert_VIB @RalfGabriels @RobbinBouwmees @SaraDuf79861163 @mtpmmaia @VIBProteomxCore @ImpensLab

Han Remaut avatar
⟳ Impens Lab retweeted
Han Remaut@RemautHan·11 Dec 2023

Meet SlyB, a lipoprotein that forms stress-induced #lipidraft in the bacterial outer membrane. Off the hands of the great @ArneJanssens95 and @nguyenson85, in collaboration with @JFClab @ImpensLab and Alex Pak lab. @structbiolbxl @BECM_VIB nature.com/articles/s41586-0…

VIB avatar
⟳ Impens Lab retweeted
VIB@VIBLifeSciences·2 Oct 2023

👏Congratulations to @kkariko & @weissmanlab on becoming #NobelPrize laureates. A lifetime achievement celebrating their important research on #mRNA technology in vaccines. 🤔Did you know VIB, together with @VUBrussel, @ugent and participation of several international institutes helped establish the #BAXERNA consortium to further explore the potential of mRNA vaccines?

Post attachment
VIB Medical Biotechnology avatar
⟳ Impens Lab retweeted
VIB Medical Biotechnology@VIB_CMB·28 Feb 2023

Research on #Moyamoya disease @ImpensLab: "Rare diseases result from dysregulated, often yet unknown molecular pathways. Investigating these conditions can lead to groundbreaking fundamental discoveries while opening treatment options for the patients."

Post attachment
Impens Lab avatar
Impens Lab@ImpensLab·31 Jan 2023

We are very excited and extremely grateful to receive this #ERCCoG grant from @ERC_Research. It is a recognition for the whole team and we thank @VIB_CMB @ugent @ugent_fge @VIBLifeSciences @FWOVlaanderen and many others for their continuous support!

🎊 More wonderful @ERC_Research news! @ImpensLab has received an #ERC Consolidator grant for his research on #Moyamoya disease (#MMD). With this grant, the Impens Lab hopes to provide unprecedented insight into MMD-related immune responses! 👉 https://t.co/2iqIVzJ4zq

Post attachment
Impens Lab avatar
Impens Lab@ImpensLab·31 Dec 2022

Another wonderful story from the Radoshevich lab. A must-read (and watch!) for all Listeria and comet tail aficionados.

This tweet is unavailable

VIB avatar
⟳ Impens Lab retweeted
VIB@VIBLifeSciences·17 Oct 2022

💉 Francis Impens and team (@ImpensLab @VIB_PRC @VIB_CMB) design an mRNA vaccine against Listeria and open the door for other antibacterial vaccines. https://t.co/eqWjTA2asv

Post attachment
Impens Lab avatar
Impens Lab@ImpensLab·17 Oct 2022

Finally published! Thank you all co-authors for their priceless contribution! Here we designed mRNA vaccine formulations against Listeria using immunopeptidomics Looking forward to continue our efforts to tackle other intracellular bacterial pathogens tinyurl.com/vaccineListeria

Impens Lab avatar
Impens Lab@ImpensLab·16 Sep 2022

Happy to share our new review on Moyamoya disease and RNF213, a disorder for which the etiology is still unknown. Here, we examined the recent body of literature suggesting immune-related insults as a trigger for Moyamoya disease onset. cell.com/trends/molecular-me…